Risperidone in the treatment of psychotic depression

Chanoch Miodownik, Vladimir Lerner

    Research output: Contribution to journalArticlepeer-review

    16 Scopus citations


    Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

    Original languageEnglish
    Pages (from-to)335-337
    Number of pages3
    JournalClinical Neuropharmacology
    Issue number6
    StatePublished - 1 Dec 2000


    • 5HT receptors
    • Monotherapy
    • Psychotic depression
    • Risperidone
    • α2-adrenergic affinities

    ASJC Scopus subject areas

    • Pharmacology
    • Clinical Neurology
    • Pharmacology (medical)


    Dive into the research topics of 'Risperidone in the treatment of psychotic depression'. Together they form a unique fingerprint.

    Cite this